Skip to main content
SpringerLink
Log in

Early-phase trials used in reimbursement submissions in Canada

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Raymakers AJN, et al. Early-Phase Clinical Trials and Reimbursement Submissions to the Pan-Canadian Oncology Drug Review. PharmacoEconomics : 19 Jan 2021. Available from: URL: https://doi.org/10.1007/s40273-020-00995-3

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Early-phase trials used in reimbursement submissions in Canada. PharmacoEcon Outcomes News 871, 14 (2021). https://doi.org/10.1007/s40274-021-7452-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7452-2

Search

Navigation